| Name | Title | Contact Details |
|---|---|---|
Wendy Vargas |
VP Global CO Project Leader Head, Rare Disease, Rare Blood Disorders, Oncology | Profile |
Sophie Forge |
VP - Global Head of Digital R&D Pipeline and Project analytics | Profile |
Andrey Malyy |
Global Head of Information Technology Solutions, Innovation, CX and Mobile | Profile |
Arnaud Robert |
Executive Vice President and Chief Digital Officer | Profile |
Michael Shanno |
Head of Digital and Information Technology | Profile |
PMV is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey.
Processo Partners, In is a Miami, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Companys principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through ...
AzoRx, Inc. is a Kalamazoo, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.